The results of the migration and invasion assays demonstrated that elevated ADORA1 expression significantly enhanced glioma cell motility, whereas reduced ADORA1 expression markedly diminished cell movement (Figures 4C, D). Here, ADORA1 is linked to central nervous system cancer.